SC 13D

Company

Anixa Biosciences Inc

Filed

February 15, 2018

Accession Number

0001513162-18-000050

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →